The effectiveness of this workshop will be assessed by tracking the number of collaborations established between investigators and incorporation of these investigations into clinical protocols. The number of objectives relating to osteonecrosis in future ALL protocols will be tracked and could impact quality-of-life issues and cancer survivorship. The incidence of osteonecrosis will also be tracked and compared in current and future ALL studies. There will be an electronic post-meeting evaluation.
